GHU Logo
The Great Heights University Library
Academic discovery, digital access, and research support

Cancer-Targeted Drug Delivery (Record no. 8347)

MARC details
000 -LEADER
fixed length control field 04408nam a22006375i 4500
001 - CONTROL NUMBER
control field 978-1-0716-4374-7
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260610083719.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 250129s2025 xxu| s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781071643747
-- 978-1-0716-4374-7
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-1-0716-4374-7
Source of number or code doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS199.5
072 #7 - SUBJECT CATEGORY CODE
Subject category code TCB
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code SCI010000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code TCB
Source thema
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.6
Edition information 23
245 10 - TITLE STATEMENT
Title Cancer-Targeted Drug Delivery
Medium [electronic resource] /
Statement of responsibility, etc. edited by Ülo Langel.
250 ## - EDITION STATEMENT
Edition statement 1st ed. 2025.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York, NY :
Name of producer, publisher, distributor, manufacturer Springer US :
-- Imprint: Humana,
Date of production, publication, distribution, manufacture, or copyright notice 2025.
300 ## - online resource
Extent XII, 232 p. 24 illus., 22 illus. in color.
Other physical details online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
341 0# - ACCESSIBILITY CONTENT
Textual assistive features Table of contents navigation
Source onix
341 0# - ACCESSIBILITY CONTENT
Textual assistive features Single logical reading order
Source onix
341 0# - ACCESSIBILITY CONTENT
Textual assistive features Short alternative textual descriptions
Source onix
341 0# - ACCESSIBILITY CONTENT
Textual assistive features Use of color is not sole means of conveying information
Source onix
341 0# - ACCESSIBILITY CONTENT
Textual assistive features Use of high contrast between text and background color
Source onix
341 0# - ACCESSIBILITY CONTENT
Textual assistive features Next / Previous structural navigation
Source onix
341 0# - ACCESSIBILITY CONTENT
Textual assistive features All non-decorative content supports reading without sight
Source onix
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Encoding format PDF
Source rda
490 1# - SERIES STATEMENT
Series statement Methods in Pharmacology and Toxicology,
International Standard Serial Number 1940-6053
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Application of Graphene Oxide in Tumor Targeting and Tumor Therapy -- Antitumoral Effect on Liver Cancer of a Tumor Penetrating and Interfering Peptide -- Computer-Aided Design for Cancer-Targeted Peptide Drugs -- Advances in the Manufacturing of CAR-NK Cells for Cancer Immunotherapy -- Addressing the Blood-Brain Barrier: Overcoming Glioblastoma Drug Delivery -- Advances in Cancer Gene Therapy: Strategies, Delivery Methods, and Challenges -- Targeted Tumor Delivery Using Extracellular Vesicles -- Peptide-Assisted CRISPR/Cas9 Delivery to Tumors -- Identification of Organ- and Disease-Specific Homing Peptides Using In Vivo Peptide Phage Display -- Cancer Vaccines.
520 ## - SUMMARY, ETC.
Summary, etc. This detailed volume explores the frontiers of tumor targeting approaches in the field of tumor-targeted drug delivery and cancer therapy. Several topics involve the improvement of cancer detection and treatment using nanotechnologies, where the main challenge to transition from the laboratory to the clinic, with more effective, targeted, and less invasive treatments. Written for the Methods in Pharmacology and Toxicology series, chapters provide the kind of detailed implementation advice needed for successful future studies. Authoritative and innovative, Cancer-Targeted Drug Delivery serves as the ideal reference for researchers using current cutting-edge technologies for tumor-targeting of drugs.
532 8# - ACCESSIBILITY NOTE
Summary of accessibility Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com.
532 8# - ACCESSIBILITY NOTE
Summary of accessibility No reading system accessibility options actively disabled
532 8# - ACCESSIBILITY NOTE
Summary of accessibility Publisher contact for further accessibility information: accessibilitysupport@springernature.com
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug delivery systems.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer
General subdivision Treatment.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nanomedicine.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Delivery.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer Therapy.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer Nanotechnology.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Langel, Ülo.
Relator term editor.
Authority record control number or standard number (orcid)0000-0001-6107-0844
Real World Object URI https://orcid.org/0000-0001-6107-0844
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer Nature eBook
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9781071643730
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9781071643754
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9781071643761
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Methods in Pharmacology and Toxicology,
International Standard Serial Number 1940-6053
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/978-1-0716-4374-7">https://doi.org/10.1007/978-1-0716-4374-7</a>
912 ## -
-- ZDB-2-PRO

No items available.